Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family
- PMID: 1279421
- DOI: 10.1016/0166-6851(92)90129-8
Neutralization-sensitive merozoite surface antigens of Babesia bovis encoded by members of a polymorphic gene family
Abstract
Monospecific antibodies against native and recombinant versions of the major merozoite surface antigen (MSA-1) of Babesia bovis neutralize the infectivity of merozoites from Texas and Mexico strains in vitro. Sequence analysis shows that MSA-1 and a related, co-expressed 44 kDa merozoite surface protein (MSA-2) are encoded by members of a multigene family previously designated BabR. BabR genes, originally described in Australia strains of B. bovis, are notable because their marked polymorphism is apparently mediated by chromosomal rearrangements, but protein products of BabR genes have not previously been identified. The 3' terminal 173 nucleotides of the MSA-1 gene, including 60 nucleotides of untranslated sequence, are highly similar to the 3' terminal sequences of BabR 0.8 (84% identity) and MSA-2 (94% identity). Alignment of the predicted protein sequences demonstrates significant overall homology between MSA-1 and MSA-2, and between both proteins and the amino terminal BabR sequence. MSA-1 nucleic acid probes also hybridize weakly to genomic DNA from the Australia 'L' strain, even though this strain does not express merozoite surface epitopes cross-reactive with MSA-1 or MSA-2. Hybridization of these same probes to genomic DNA from the cloned Mexico strain reveals a pattern of bands compatible with two copies each of MSA-1 and MSA-2. Proteins encoded by this B. bovis gene family have been designated variable merozoite surface antigens (VMSA). The extent and mechanism of VMSA polymorphism among strains will be important when evaluating the role these surface proteins have in the host-parasite interaction, including immunity to blood stages.
Similar articles
-
Surface epitope localization and gene structure of a Babesia bovis 44-kilodalton variable merozoite surface antigen.Mol Biochem Parasitol. 1992 Oct;55(1-2):75-83. doi: 10.1016/0166-6851(92)90128-7. Mol Biochem Parasitol. 1992. PMID: 1279420
-
The Babesia bovis merozoite surface antigen 2 locus contains four tandemly arranged and expressed genes encoding immunologically distinct proteins.Infect Immun. 2002 Jul;70(7):3566-75. doi: 10.1128/IAI.70.7.3566-3575.2002. Infect Immun. 2002. PMID: 12065497 Free PMC article.
-
Persistence of antibodies against epitopes encoded by a single gene copy of the Babesia bovis merozoite surface antigen 1 (MSA-1).J Parasitol. 1998 Apr;84(2):449-52. J Parasitol. 1998. PMID: 9576525
-
Genetic basis for GPI-anchor merozoite surface antigen polymorphism of Babesia and resulting antigenic diversity.Vet Parasitol. 2006 May 31;138(1-2):33-49. doi: 10.1016/j.vetpar.2006.01.038. Epub 2006 Mar 23. Vet Parasitol. 2006. PMID: 16551492 Review.
-
A malaria merozoite surface protein (MSP1)-structure, processing and function.Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:37-42. doi: 10.1590/s0074-02761992000700004. Mem Inst Oswaldo Cruz. 1992. PMID: 1343716 Review.
Cited by
-
Genetic Diversity of Merozoite Surface Antigens in Global Babesia bovis Populations.Genes (Basel). 2023 Oct 13;14(10):1936. doi: 10.3390/genes14101936. Genes (Basel). 2023. PMID: 37895285 Free PMC article.
-
Exploring the landscape of Babesia bovis vaccines: progress, challenges, and opportunities.Parasit Vectors. 2023 Aug 10;16(1):274. doi: 10.1186/s13071-023-05885-z. Parasit Vectors. 2023. PMID: 37563668 Free PMC article. Review.
-
Babesia gibsoni Whole-Genome Sequencing, Assembling, Annotation, and Comparative Analysis.Microbiol Spectr. 2023 Aug 17;11(4):e0072123. doi: 10.1128/spectrum.00721-23. Epub 2023 Jul 11. Microbiol Spectr. 2023. PMID: 37432130 Free PMC article.
-
Developing Anti-Babesia bovis Blood Stage Vaccines: A New Perspective Regarding Synthetic Vaccines.Int J Mol Sci. 2023 Mar 9;24(6):5219. doi: 10.3390/ijms24065219. Int J Mol Sci. 2023. PMID: 36982294 Free PMC article. Review.
-
Imidazo[1,2-a]pyridine: a Highly Potent Therapeutic Agent Clears Piroplasm Infection In Vitro.Acta Parasitol. 2023 Mar;68(1):249-256. doi: 10.1007/s11686-022-00655-w. Epub 2023 Jan 13. Acta Parasitol. 2023. PMID: 36637693
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
